In line with such findings we also observed a concordant decrease in CDK6 levels and alterations in the cell cycle of all three GBM lines examined confirming previous work which has highlighted the role of SUMO1–conjugation in CDK6 stability/cell cycle progression in GBM19. The gene discussed is CDK6; the disease is glioblastoma.